Patient-reported outcome claims in European and United States orphan drug approvals

Eitemau Tebyg

• Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
  gan: Jarosławski, Szymon, et al.
  Cyhoeddwyd: (2018)
• Quantifying the persisting orphan-drug shortage public health crisis in the United States
  gan: Jarosławski, Szymon, et al.
  Cyhoeddwyd: (2016)
• Why “American Patients First” is likely to raise drug prices outside of the United States
  gan: Monique Dabbous, et al.
  Cyhoeddwyd: (2019-01-01)
• Why “American Patients First” is likely to raise drug prices outside of the United States
  gan: Dabbous, Monique, et al.
  Cyhoeddwyd: (2019)
• Non-profit drug research and development: the case study of Genethon
  gan: Szymon Jarosławski, et al.
  Cyhoeddwyd: (2019-01-01)